The Group actively seeks diversified development and has expanded its business into the pharmaceutical industry, focusing on the development in two major areas, being pharmaceutical inspection and stem cell, with a middle- and long-term goal of developing into a “Pharmaceutical expert” and “Stem cell expert”. With the mission of “Improving human life and health”, the Group targets to become a respectable company in the future.

The chairman of the Group have nearly 20 years of experience in property development in the PRC, who have led the development of the Group and established a new management team to lead the Group into the new healthcare industry.
In the pharmaceutical inspection area, we became a strategic partner of Irvine Pharmaceutical Services Inc., which is based in the United States and has leading global pharmaceutical inspection technologies; leading local and international experts in the stem cell area partnered with Sino Harbour to expand into the stem cell industry.

With the increasing job opportunities and the improving living quality of residents, there has been a growing demand for residential properties in Jiangxi Province. With relatively lower living expenses compared to other developed cities and provinces, as well as the improving national railway system and transport network, Jiangxi Province is able to attract people demanding higher living quality, which in turn benefits the residential property market in Jiangxi Province.